Adenocarcina of the mouse prostate growth inhibition by celecoxib: Downregulation of transcription factors involved in COX-2 inhibition

This publication has 28 references indexed in Scilit:

• Celecoxib Inhibits Prostate Cancer Growth: Evidence of a Cyclooxygenase-2-Independent Mechanism
  Clinical Cancer Research, 2005
• Angiopoietin/Tie2 signaling, tumor angiogenesis and inflammatory diseases
  Frontiers in Bioscience-Landmark, 2005
• Regression of Mouse Prostatic Intraepithelial Neoplasia by Nonsteroidal Anti-inflammatory Drugs in the Transgenic Adenocarcinoma Mouse Prostate Model
  Clinical Cancer Research, 2004
• LAPAROSCOPIC PARTIAL NEPHRECTOMY AND PROSTATECTOMY: WEIGHING THE COSTS AND THE BENEFITS
  Journal of Urology, 2004
• Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study
  Cancer, 2003
• The management of prostate cancer
  Nursing Standard, 2003
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
  Cell, 1995
• Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: Effects of fatty acids and cyclooxygenase inhibitors
  International Journal of Cancer, 1994
• NSAIDs and risk of upper gastrointestinal bleeding
  The Lancet, 1991
• Early prostaglandin E synthesis is an obligatory event in the induction of cell proliferation in mouse epidermis in vivo by the phorbol ester TPA
  Biochemical and Biophysical Research Communications, 1980